Kusajili – Clinical trials directory

Result of your search per sponsor: Christoph KAPITZA, MD

Woman and Man Max 99 years
Christoph KAPITZA, MD Update Il y a 4 ans

Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2 The objective of this study is to test whether Lixisenatide (AVE0010) restores first phase and improves second phase insulin response in subjects with diabetes mellitus type 2.

Country Germany
organs None
Specialty None

Closed trial

More information